Bionik LaboratoriesBNKL 
$0.100.00%24h
0.00%24h
Global rank36621
Market cap$1.25M
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E0
P/S0.69
Revenue$1.81M
Earnings-$4.95M
Dividend yield-
Main Sector
Healthcare
EPS for Bionik Laboratories (BNKL)
Bionik Laboratories has an EPS of $-1.78. In 2021, the company made an earnings per share (EPS) of $-2.66. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BNKL
-
Value:-
EPS history for Bionik Laboratories from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$1.78 | -33.08% |
| 2021 | -$2.66 | -52.58% |
| 2020 | -$5.61 | - |
View the highest EPS stocks
